Melanoma is considered to be the most life-threatening form of skin cancer. However, in recent decades the emergence of immunotherapy has made great strides in improving survival. What are the mortality rates for patients with melanoma and how have they changed?
Acute myeloid leukemia (AML) progresses more rapidly than other forms of leukemia. As such, if you or your patient are concerned they may have AML it is important to educate them on the symptoms and risk factors of the disease, as well as how to detect it and what treatments it could entail.
Multiple myeloma (MM) is not a disease with a known cure, but recent studies have suggested that focusing on boosting immunity in patients with MM may help their chances at longer-term survival. What are these immunity-focused treatment options?
Multiple myeloma is an uncommon form of cancer, and one that may not produce symptoms right away. Because of this, patients with higher risk due to family history, exposure, or other reasons may need more education about it. How can you explain multiple myeloma to your patients?
Despite relying on glycolysis, there is growing evidence that many tumor types still have high levels of mitochondrial energy metabolism and functioning oxidative phosphorylation. One such subset of tumors is melanoma, potentially playing a role in both tumor progression and resistance to therapy. This has led researchers to wonder whether targeting mitochondrial respiration could be…
Access a detailed treatment regimen chart for ovarian cancer, with a focus on primary chemotherapy/primary adjuvant therapy with IV and IP options.
Get the most up-to-date treatment regimens for adult T-cell leukemia/lymphoma (a non-Hodgin leukemia), such as zidovudine + alpha-interferon.
Access treatment regimens for myelodysplastic syndromes, including options such as lenalidomide, azacitadine, and decitabine.
View detailed treatment regimens for head and neck cancers, with options such as cisplatin, cisplatin + radiotherapy, and more.
Get current regimens for occult primary tumors, such as adenocarcinoma or carcinoma not otherwise specified (NOS) and more.
